SSAC:LSE:LSE-iShares MSCI ACWI UCITS ETF USD (Acc) GBP (GBX)

ETF | Others |

Last Closing

USD 6869

Change

-8.00 (-0.12)%

Market Cap

N/A

Volume

0.03M

Analyst Target

N/A
Analyst Rating

N/A

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-10-30 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
XNID:LSE Xtrackers Nifty 50 Swap UCITS ..

-1.04 (-0.37%)

USD 292,109.69B
0R1O:LSE Amazon.com Inc.

+4.50 (+2.37%)

USD 1,607.29B
0R1I:LSE NVIDIA Corp.

-1.28 (-0.91%)

USD 618.20B
LCJD:LSE Amundi MSCI Japan (DR) UCITS E..

+0.08 (+0.42%)

USD 559.82B
LCJP:LSE Lyxor Core MSCI Japan (DR) UCI..

+0.06 (+0.44%)

USD 500.71B
0R1G:LSE Home Depot Inc.

N/A

USD 373.16B
0QZK:LSE Coca-Cola Co.

+0.70 (+1.06%)

USD 266.08B
0QZO:LSE 0QZO

+0.15 (+0.16%)

USD 258.54B
PRJU:LSE Amundi Index Solutions - Amund..

+0.11 (+0.35%)

USD 204.07B
0QZ3:LSE Qualcomm Inc.

-4.06 (-2.34%)

USD 202.26B

ETFs Containing SSAC:LSE

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 15.42% 75% C 71% C-
Dividend Return N/A N/A N/A N/A N/A
Total Return 15.42% 75% C 72% C
Trailing 12 Months  
Capital Gain 26.54% 70% C- 67% D+
Dividend Return N/A N/A N/A N/A N/A
Total Return 26.54% 70% C- 68% D+
Trailing 5 Years  
Capital Gain 69.88% 80% B- 79% B-
Dividend Return N/A N/A N/A N/A N/A
Total Return 69.88% 80% B- 79% B-
Average Annual (5 Year Horizon)  
Capital Gain 11.96% 71% C- 73% C
Dividend Return 11.96% 71% C- 72% C
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 10.71% 63% D 78% C+
Risk Adjusted Return 111.63% 97% N/A 98% N/A
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (GBX)

Quarterly Financials (GBX)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

What to not like:

There is nothing we particularly dislike